HCPLive

JUNE 8, 2025

Meta-analysis indicates obicetrapib's effects on new-onset diabetes risk are consistent with other CETP inhibitors, suggesting a class effect. Larger, longer trials are needed to fully understand obicetrapib's protective effects on new-onset diabetes risk.

Diabetes 66

Diabetes CME Pediatrics Heart Failure 66

JAMA Cardiology

JUNE 24, 2025

This cohort study nested within the CARDIA study examines whether gestational diabetes is a mediator or marker of the association between prepregnancy cardiovascular health and midlife subclinical cardiovascular disease.

Diabetes 53

Diabetes Cardiovascular Disease 53

Cardiovascular Diabetology

JUNE 6, 2025

Diabetic women with HFpEF represent a high-risk subgroup, particularly af. Heart failure with preserved ejection fraction (HFpEF) poses a significant global health challenge, disproportionately affecting women.

Preserved Ejection Fraction 121

Preserved Ejection Fraction Diabetes Ischemia STEMI 121

Frontiers in Cardiovascular Medicine

JUNE 30, 2025

BackgroundCardiovascular disease (CVD) is a leading cause of morbidity in patients with type 2 diabetes mellitus (T2DM). Its use alongside the TyG index offers a cost-effective approach for enhancing cardiovascular risk stratification in diabetes care. Non-HDL-c and RC were calculated from fasting lipid profiles.

Cholesterol 52

Cholesterol Diabetes BMI Outpatient 52

Frontiers in Cardiovascular Medicine

JULY 13, 2025

Diabetic cardiomyopathy (DCM), a common diabetic complication independent of hypertension, coronary heart disease and heart valve disease is a major cause of cardiovascular mortality. The pathogenesis of DCM is complex.

Diabetes 52

Diabetes Cardiomyopathy Heart Valves Physiology 52

HCPLive

JUNE 8, 2025

Lopez reviews findings from an analysis of ARISE-HF highlighting racial and ethnic differences in baseline characteristics and diabetic cardiomyopathy disease progression.

Cardiomyopathy 69

Cardiomyopathy Diabetes 69

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2025

BackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain.

Diabetes 52

Diabetes BMI Obesity Outpatient 52

HCPLive

JUNE 6, 2025

New research has indicated that glucagon-like peptide-1 receptor agonists result in lower all-cause mortality and risk of cardiovascular events in patients with concurrent sleep apnea and type 2 diabetes.

Diabetes 59

Diabetes Research 59

Frontiers in Cardiovascular Medicine

MAY 22, 2025

PurposeSodium glucose co-transporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated cardioprotective effects in people with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD).

Diabetes 52

Diabetes BMI Cardiovascular Disease Research 52

Medical Xpress - Cardiology

JUNE 6, 2025

A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according to research presented Tuesday at the British Cardiovascular Society conference in Manchester.

Diabetes 109

Diabetes Heart Disease Heart Failure Research 109

Frontiers in Cardiovascular Medicine

MARCH 14, 2025

As of now, there are no data to support its use as a treatment for diabetic cardiomyopathy (DCM) and the mechanism behind the effect is unclear as well. BackgroundZhigancao Decoction (ZGCD) is derived from Treatise on Febrile Diseases and is traditionally prescribed for treating a variety of cardiovascular conditions.

Pharmacology 52

Pharmacology Cardiomyopathy Diabetes Blood Pressure 52

Frontiers in Cardiovascular Medicine

MARCH 30, 2025

BackgroundRecent studies have found that heart rate response is impaired in patients with type 2 diabetes. However, it remains unclear how chronotropic competence changes in these patients and which chronotropic index is more closely related to type 2 diabetes. had type 2 diabetes and 57.2% did not have type 2 diabetes.

Diabetes 40

Diabetes Exercise Hospital Research 40

Med Page Today

JUNE 9, 2025

(MedPage Today) -- A modified DASH-style diet modestly reduced blood pressure (BP) for patients with type 2 diabetes and hypertension, the DASH4D randomized trial showed. With low-sodium DASH4D meals featuring lower carbs, higher unsaturated fats.

Blood Pressure 102

Blood Pressure Diet Diabetes Hypertension 102

Medical Xpress - Cardiology

JULY 3, 2025

Poor prepregnancy cardiovascular health is associated with a higher risk of developing gestational diabetes and coronary artery calcium in midlife, according to a recent Northwestern Medicine study published in JAMA Cardiology.

Diabetes 72

Diabetes 72

HCPLive

JULY 8, 2025

Bruce Culleton, MD Credit: ProKidney ProKidney Corp has announced statistically significant and clinically meaningful positive topline results from the full Group 1 modified intent-to-treat (mITT) population of the phase 2 REGEN-007 trial evaluating rilparencel in patients with chronic kidney disease (CKD) and diabetes. References ProKidney.

Diabetes 64

Diabetes Kidney Disease CME Pediatrics 64

The British Journal of Cardiology

JULY 8, 2025

The initial diagnostic assessment revealed significant metabolic derangements consistent with diabetic ketoacidosis, accompanied by hyperkalaemia. He was haemodynamically unstable, and his initial electrocardiogram (ECG) revealed a Brugada type 1 ECG pattern.

Diabetes 76

Diabetes Electrocardiogram Arrhythmia Article 76

Cardiovascular Diabetology

JULY 10, 2025

Diabetes is a leading cause of mortality worldwide, primarily due to cardiovascular diseases (CVD). Arterial stiffness is a CVD predictor and is associated with increased mortality in diabetic individuals.

Diabetes 52

Diabetes Cardiovascular Disease Research 52

The British Journal of Cardiology

JUNE 10, 2025

This case report describes a young man in his early thirties with insulin-dependent diabetes mellitus and ulcerative colitis, who developed acute myocardial infarction (AMI) during an acute flare-up of ulcerative colitis.

Myocardial Infarction 40

Myocardial Infarction Diabetes Outcomes Article 40

CTVS

NOVEMBER 18, 2024

Diabetes affects millions of Americans. If managed well through proper diet and medication, those with diabetes can lead full and active lives. There are however some serious complications commonly associated with diabetes, like cardiovascular disease, kidney disease, and PAD (Peripheral Artery Disease).

Peripheral Arterial Disease 40

Peripheral Arterial Disease Diabetes Kidney Disease Cardiovascular Disease 40

Cardiovascular Diabetology

JULY 9, 2025

Impaired Ca2+ handling is involved in diabetic cardiomyopathy (DCM) progression. The activation of acid sphingomyelinase (ASMase) stimulated cardiomyocytes apoptosis and caused DCM. Here, we aimed to investigate.

Cardiomyopathy 52

Cardiomyopathy Diabetes Research 52

HCPLive

JUNE 7, 2025

Khan’s presentation indicates that combination screening is the optimal method of identifying heart failure risk while minimizing the percentage of cases missed.

Heart Failure 93

Heart Failure Diabetes 93

Open Heart

JANUARY 11, 2025

We aimed to examine the impact of diabetes on 30-day mortality, 30-day readmission and compare outcomes between TAVR and sAVR. Diabetes was present in 36.4% However, sAVR patients with diabetes had a higher adjusted risk of 30-day mortality (aHR=1.13 (1.01–1.25)) but not readmission (aHR=0.92 (0.84–1.01)).

Aortic valve 52

Aortic valve TAVR Aortic Diabetes 52

HCPLive

MAY 28, 2025

Ehsan Rahimy, MD; David G.

Diabetes 84

Diabetes 84

Open Heart

JANUARY 20, 2025

Type 2 Diabetes Mellitus (T2DM) increases cardiovascular risk, requiring early detection, self-management, blood pressure, glucose, and cholesterol treatment. SGLT2i may improve cardiovascular outcomes and diabetes treatment in the elderly.

Diabetes 52

Diabetes Heart Failure Blood Pressure Hypertension 52

HCPLive

JUNE 9, 2025

Lopez, MD Fact checked by: Abigail Brooks, MA Conference | Heart in Diabetes Lopez discusses the evolving understanding of the utility of SGLT2 inhibitors and GLP-1 RAs in heart failure care, including both HFpEF and HFrEF. I wouldn't necessarily jump to say that these medications are harmful.”

Heart Failure 80

Heart Failure Preserved Ejection Fraction Diabetes Obesity 80

Medical Xpress - Cardiology

JUNE 10, 2025

million adults in the United States had diagnosed diabetes in 2021, according to the Centers for Disease Control and Prevention. Of these, about 90% to 95% had type 2 diabetes. An estimated 38.1

Blood Pressure 40

Blood Pressure Diet Diabetes Hypertension 40

HCPLive

MAY 13, 2025

Hosts explore Luna Diabetes automated insulin delivery system, designed to enhance sleep and improve glucose control for people with diabetes who use pens.

Diabetes 59

Diabetes 59

Cardiovascular Diabetology

MAY 25, 2025

Sodiumglucose transport protein-2 (SGLT2) inhibitors, initially developed for glycemic control in type 2 diabetes mellitus (T2DM), have emerged as potential cardioprotective agents, reducing cardiovascular mo.

Myocardial Infarction 75

Myocardial Infarction Diabetes 75

CardiacWire

MARCH 12, 2025

One of the biggest risk factors for patients who need coronary revascularization is diabetes, and a new study in JAMA suggests CABG could be a better option than FFR-guided PCI when it comes to long term outcomes for these patients. Patients with T2D who underwent PCI had a 44% higher MACCE risk than those who underwent CABG.

Diabetes 59

Diabetes Stents Stent Risk Factors 59

Frontiers in Cardiovascular Medicine

JUNE 26, 2025

We explore PVAT's molecular interactions in obesity, diabetes, and hypertension, elucidating its contribution to inflammation, oxidative stress, and endothelial dysfunction. Advanced imaging techniques, notably the perivascular fat attenuation index (FAI) and circulating biomarkers, are highlighted for early CVD detection.

Cardiovascular Disease 52

Cardiovascular Disease Pharmacology Biomarkers Obesity 52

Med Page Today

JUNE 22, 2025

(MedPage Today) -- CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with or without type 2 diabetes, a pair of phase IIIa trials found. In REDEFINE 1, which included 3,417.

Diabetes 66

Diabetes Obesity 66

HCPLive

MAY 14, 2025

Adult-onset T1D significantly raises cardiovascular disease and mortality risks, highlighting the need for improved management and prevention strategies.

Diabetes 59

Diabetes Cardiovascular Disease 59

Cardiovascular Diabetology

JULY 10, 2025

Pre-pregnancy hypertension (HTN), hypertensive disorders of pregnancy (HDP), and diabetes have been linked to increased risk of post-pregnancy coronary heart disease (CHD) and all-cause mortality, but few stud.

Heart Disease 52

Heart Disease Hypertension Diabetes Research 52

JAMA Cardiology

JUNE 3, 2025

This cross-sectional study evaluated the changes in the proportion of US adults who were unaware they had hypertension, diabetes, or a high cholesterol level using 2013 to 2023 data from the National Health and Nutrition Examination Survey.

Cholesterol 49

Cholesterol Hypertension Diabetes 49

Cardiovascular Diabetology

JULY 2, 2025

Diabetes mellitus elevates the risk of developing heart failure and increases associated mortality rates. While the clinical features of diabetic cardiomyopathy have been extensively studied, the effects of d.

Diabetes 52

Diabetes Heart Failure Cardiomyopathy Research 52

Dr. Paddy Barrett

NOVEMBER 15, 2024

No Diabetes or Pre-Diabetes. The Life Essential 8 are a set of factors that significantly influence your risk of heart disease and early death, including: Regular Physical Activity. Not smoking. Adequate Sleep. Normal Cholesterol Levels. Normal Blood Pressure.

Heart Disease 98

Heart Disease Obesity Blood Pressure Cholesterol 98

Science Daily - Heart Disease

APRIL 8, 2025

New research has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes -- not the presence of certain fats, but their suppression. The study challenges the conventional belief that a type of fat called ceramides accumulates in blood vessels causing inflammation and health risks.

Obesity 63

Obesity Cardiovascular Disease Diabetes Research 63